OverviewChartNewsTraderScreen

Patient Access Solutions, Inc./  US70324A2087  /

Nasdaq Other OTC
2024-05-21  8:25:35 PM Chg. 0.0000 Volume Bid- Ask- High Low
0.0000USD 0.00% 969,392
Turnover: .9694		 -Bid Size: - -Ask Size: - 0.0000 0.0000
GlobeNewswire 05-16 Fortrea Appoints Machelle Sanders to Board of Directors
GlobeNewswire 05-16 CVRx Announces Key Senior Leadership Team Hires
GlobeNewswire 05-16 ENT and Allergy Associates Reinforces Its Commitment to Future Growth by Welcoming Eight New Special...
GlobeNewswire 05-15 INVO Reports Record First Quarter 2024 Financial Results
GlobeNewswire 05-15 STRATA Skin Sciences Reports First Quarter 2024 Financial Results and Provides a Corporate Update
GlobeNewswire 05-15 Galapagos and Blood Centers of America announce strategic collaboration to accelerate Galapagos’ dec...
GlobeNewswire 05-15 Perspective Therapeutics Provides Recent Business Highlights and Reports Fiscal Q1 2024 Results
GlobeNewswire 05-14 Nyxoah Reports First Quarter 2024 Financial and Operating Results
GlobeNewswire 05-14 Versant Diagnostics Announces the Acquisition of Associate Pathologists of Joliet, Ltd. to Advance A...
GlobeNewswire 05-13 Fortrea Reports First Quarter 2024 Results
GlobeNewswire 05-10 Tevogen Bio Announces Up to $50 Million in Financing to Further Advance Operational Objectives
GlobeNewswire 05-10 Century Therapeutics Presents Preclinical Data Highlighting Advances in iPSC Platform Technology and...
GlobeNewswire 05-09 Gyre Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire 05-09 Nkarta Reports First Quarter 2024 Financial Results and Corporate Highlights
GlobeNewswire 05-09 Fate Therapeutics Announces First Lupus Patient Treated in Phase 1 Autoimmunity Study of Off-the-she...
GlobeNewswire 05-09 Century Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates
GlobeNewswire 05-08 Tarsus Reports First Quarter 2024 Financial Results and Recent Business Achievements
GlobeNewswire 05-08 Zevra Therapeutics Reports First Quarter 2024 Financial Results and Corporate Updates
GlobeNewswire 05-08 Compass Pathways Announces First Quarter 2024 Financial Results and Business Highlights
GlobeNewswire 05-08 Compass Pathways announces durable improvement in symptoms through 12 weeks in open-label phase 2 st...
GlobeNewswire 05-07 Pacira BioSciences Reports First Quarter 2024 Financial Results and Announces $150 Million Share Rep...
GlobeNewswire 05-07 Charlesbank Capital Partners Announces the Formation of Kleer-Membersy, Combining the Nation’s Two L...
GlobeNewswire 05-07 Neuronetics Reports Record First Quarter 2024 Financial and Operating Results
GlobeNewswire 05-07 Madrigal Pharmaceuticals Reports First-Quarter 2024 Financial Results and Provides Corporate Updates
GlobeNewswire 05-07 X4 Pharmaceuticals Reports First-Quarter 2024 Financial Results and Provides Corporate Updates